• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Arrhythmia Monitoring Devices Market

    ID: MRFR/MED/5251-CR
    134 Pages
    Rahul Gotadki
    May 2019

    Arrhythmia Monitoring Devices Market Report Information By Device Type (Resting ECG, Event Monitor, Holter Monitor, Others), Application (Tachycardia, Bradycardia, Others), End User (Hospitals and Clinics, Others) and Region - Forecast till 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Arrhythmia Monitoring Devices Market Research Report - Forecast till 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Arrhythmia Monitoring Devices Market Summary

    The Global Arrhythmia Monitoring Devices Market is projected to grow from 5.6 USD Billion in 2024 to 10.7 USD Billion by 2035.

    Key Market Trends & Highlights

    Arrhythmia Monitoring Devices Key Trends and Highlights

    • The market is expected to witness a compound annual growth rate (CAGR) of 6.07 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 10.7 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 5.6 USD Billion, reflecting a strong foundation for future expansion.
    • Growing adoption of advanced monitoring technologies due to increasing prevalence of arrhythmias is a major market driver.

    Market Size & Forecast

    2024 Market Size 5.6 (USD Billion)
    2035 Market Size 10.7 (USD Billion)
    CAGR (2025-2035) 6.07%

    Major Players

    Abbott Laboratories, BioTelemetry Inc., Fukuda Denshi Co. Ltd, Applied Cardiac Systems Inc., Medtronic plc, Nihon Kohden Corporation, Alive Cor Inc., Biotronik, GE Healthcare, Spacelabs Healthcare

    Arrhythmia Monitoring Devices Market Trends

    Arrhythmia monitoring system has been gaining significance in recent years owing to the rising cases of heart diseases. The ease of FDA approvals, increasing adoption of low-cost electrocardiogram (ECG) devices, and the increasing geriatric population are some salient causes that can propel the industry in the coming period. In addition, the mounting cases of cardiac disorders are likely to favor market expansion in the assessment period.

     However, complications related to these devices may negatively affect the expansion of the arrhythmia monitoring devices market over the assessment period.

    Drivers

    Innovation in Product to Grow the Adoption of Device among Professionals

    The on-going technical development allowing remote monitoring of cardiac rhythm in patients is expected to be one of the most salient factors that can augment the market in the coming period.  The high accuracy and efficiency provided by arrhythmia detection is expected to surge its demand, thereby raising the market. Furthermore, the growing requirement for continuous cardiac rhythm monitoring in the emergency department is expected to augment the arrhythmia monitoring devices market size in the assessment period.

    Opportunities

    Growing Incidence of CVDs to Offer Market Expansion Opportunities

    Adoption of unhealthy diet such as; consumption of a sugar-rich diet, smoking, alcoholism, and higher adoption of a sedentary lifestyle are some of the crucial factors that can offer various expansion opportunities to the arrhythmia monitoring devices industry.

    Restraints

    Associated Complications can impede the market

    Despite the propelling factors, the market can witness hindrance in the coming period. The complications related to such devices along with the rise in recalls of arrhythmia monitoring devices can bring negative impact on the arrhythmia monitoring devices market share.

    Challenges

    Lack of Resources can pose a Severe Challenge to Grow the Market

    The market is predicted to experience a challenge due to the lack of expertise. In addition, some cardiac monitoring devices may have a negative impact on patients, which is another potent challenge that can restrict the market from growing.

    Cumulative Growth Analysis

    The market is projected to Show Steady Growth in the Assessment Timeframe

    The market for arrhythmia monitoring devices is expected to experience a notable expansion in the coming period owing to the increasing cases of CVDs along with the expansion of geriatric population.

    The increasing prevalence of cardiovascular diseases is driving the demand for advanced arrhythmia monitoring devices, which are essential for timely diagnosis and effective management of heart conditions.

    U.S. Food and Drug Administration (FDA)

    Arrhythmia Monitoring Devices Market Drivers

    Rising Awareness and Education

    Increased awareness regarding heart health and arrhythmias is driving the Global Arrhythmia Monitoring Devices Market Industry. Educational initiatives by health organizations and governments aim to inform the public about the risks associated with arrhythmias and the importance of early detection. Campaigns promoting heart health have led to more individuals seeking medical advice and monitoring solutions. This heightened awareness is likely to result in increased adoption of arrhythmia monitoring devices, as patients become more proactive in managing their health. Consequently, this trend is expected to bolster market growth significantly in the coming years.

    Increasing Geriatric Population

    The global demographic shift towards an aging population significantly influences the Global Arrhythmia Monitoring Devices Market Industry. Older adults are more susceptible to arrhythmias, necessitating continuous monitoring to prevent severe complications. According to the United Nations, the number of people aged 65 and older is projected to reach 1.5 billion by 2050. This demographic trend underscores the need for effective arrhythmia management solutions. As healthcare systems adapt to cater to this growing population, the demand for monitoring devices is likely to surge, contributing to a compound annual growth rate of 6.07 percent from 2025 to 2035.

    Rising Prevalence of Cardiac Disorders

    The increasing incidence of cardiac disorders globally is a primary driver of the Global Arrhythmia Monitoring Devices Market Industry. As cardiovascular diseases continue to rise, the demand for effective monitoring solutions becomes more pronounced. For instance, the World Health Organization indicates that cardiovascular diseases are the leading cause of death worldwide, accounting for approximately 32 percent of all deaths. This alarming trend necessitates advanced monitoring devices to manage arrhythmias effectively. The market is projected to reach 5.6 USD Billion in 2024, reflecting the urgent need for innovative solutions to address this growing health crisis.

    Regulatory Support and Reimbursement Policies

    Supportive regulatory frameworks and favorable reimbursement policies are vital drivers of the Global Arrhythmia Monitoring Devices Market Industry. Governments and health authorities are increasingly recognizing the importance of arrhythmia monitoring in improving patient outcomes. As a result, they are implementing policies that facilitate the approval and reimbursement of innovative monitoring devices. This regulatory support encourages manufacturers to invest in research and development, leading to the introduction of advanced technologies. Such initiatives not only enhance market accessibility but also stimulate growth, as healthcare providers are more likely to adopt devices that are financially supported by insurance plans.

    Technological Advancements in Monitoring Devices

    Technological innovations play a crucial role in shaping the Global Arrhythmia Monitoring Devices Market Industry. The development of advanced wearable devices, mobile health applications, and remote monitoring systems enhances patient engagement and enables real-time data collection. For example, devices equipped with artificial intelligence algorithms can analyze heart rhythms more accurately, leading to timely interventions. These advancements not only improve patient outcomes but also drive market growth. As the industry evolves, the integration of telemedicine and digital health technologies is expected to further propel the market, potentially doubling its value to 10.7 USD Billion by 2035.

    Market Segment Insights

    Arrhythmia Monitoring Devices

    Based on type, the global market for cardiac arrhythmia monitoring devices is segmented into event monitor, resting ECG, implantable cardiac monitor (ICM), mobile cardiac telemetry (MCT) devices, Holter monitor, and others. Holter monitor is predicted to gain prominence in the coming period due to the introduction of wireless wearable technology in the device.

    Arrhythmia Monitoring Devices

    The Tachycardia Segment to Grow Significantly

    Based on application, the global market for arrhythmia monitoring devices market is segmented into bradycardia, tachycardia, atrial fibrillation (A-fib), premature ventricular contractions (PVC), ventricular fibrillation (V-fib), conduction disorders, and others. Among all, the tachycardia segment is expected to grow significantly during the forecast period.

    Arrhythmia Monitoring Devices

    Hospitals and Clinics to Dominate the Market

    Based on type, the global market for arrhythmia monitoring devices market is segmented into ambulatory surgery centers (ASC), diagnostic centers, hospitals & clinics, home care settings, and others. The hospitals and clinics segment accounted for a market value of USD 1,740.0 Million in 2018.

    Get more detailed insights about Arrhythmia Monitoring Devices Market Research Report - Forecast till 2032

    Key Companies in the Arrhythmia Monitoring Devices Market market include

    Industry Developments

    • Q2 2024: Medtronic receives FDA approval for LINQ II™ insertable cardiac monitor for pediatric patients Medtronic announced FDA approval for its LINQ II™ insertable cardiac monitor to be used in pediatric patients, expanding its arrhythmia monitoring device portfolio for younger populations.
    • Q2 2024: Abbott launches new Jot Dx™ insertable cardiac monitor in the U.S. Abbott introduced the Jot Dx™ insertable cardiac monitor in the United States, designed to provide advanced arrhythmia detection and remote monitoring capabilities for clinicians and patients.
    • Q3 2024: Boston Scientific announces acquisition of Preventice Solutions Boston Scientific completed the acquisition of Preventice Solutions, a company specializing in remote cardiac monitoring and wearable arrhythmia detection devices, strengthening its position in the arrhythmia monitoring sector.
    • Q3 2024: iRhythm Technologies appoints new CEO Quentin Blackford iRhythm Technologies, a leader in ambulatory cardiac monitoring, announced the appointment of Quentin Blackford as Chief Executive Officer to drive growth and innovation in arrhythmia monitoring solutions.
    • Q4 2024: Philips launches next-generation wearable ECG patch for arrhythmia detection Philips unveiled a new wearable ECG patch designed for continuous arrhythmia monitoring, offering improved comfort and data accuracy for patients in ambulatory settings.
    • Q4 2024: Biotronik receives CE Mark for BioMonitor IV implantable cardiac monitor Biotronik announced it has received CE Mark approval for its BioMonitor IV implantable cardiac monitor, enabling expanded use of the device for arrhythmia detection in Europe.
    • Q1 2025: Hill-Rom Holdings opens new cardiac monitoring device manufacturing facility in Texas Hill-Rom Holdings inaugurated a new manufacturing facility in Texas dedicated to the production of advanced cardiac arrhythmia monitoring devices, aiming to meet rising demand in North America.
    • Q1 2025: Vivaquant raises $25M Series B to expand arrhythmia monitoring device development Vivaquant secured $25 million in Series B funding to accelerate the development and commercialization of its next-generation arrhythmia monitoring devices.
    • Q2 2025: GE Healthcare partners with Mindray Medical to co-develop AI-powered arrhythmia monitoring solutions GE Healthcare and Mindray Medical announced a strategic partnership to jointly develop artificial intelligence-powered arrhythmia monitoring devices for global markets.
    • Q2 2025: iRhythm Technologies completes $100M public offering to fund arrhythmia monitoring device R&D iRhythm Technologies completed a $100 million public offering, with proceeds earmarked for research and development of new ambulatory arrhythmia monitoring devices.
    • Q3 2025: Boston Scientific receives FDA clearance for LUX-Dx™ insertable cardiac monitor Boston Scientific announced FDA clearance for its LUX-Dx™ insertable cardiac monitor, expanding its portfolio of devices for long-term arrhythmia detection.
    • Q3 2025: Abbott partners with Schiller AG to distribute arrhythmia monitoring devices in Asia-Pacific Abbott entered into a distribution partnership with Schiller AG to expand the reach of its arrhythmia monitoring devices across the Asia-Pacific region.

    Key Players

      • BioTelemetry Inc. (US)
      • Fukuda Denshi Co. Ltd (Japan)
      • Applied Cardiac Systems Inc. (US)
      • Nihon Kohden Corporation (Japan)
      • Alive Cor Inc. (US)
      • Biotronik (Germany)
      • GE Healthcare (US)
      • Spacelabs Healthcare (US)

    Future Outlook

    Arrhythmia Monitoring Devices Market Future Outlook

    The Arrhythmia Monitoring Devices Market is projected to grow at a 6.07% CAGR from 2024 to 2035, driven by technological advancements, increasing prevalence of arrhythmias, and rising healthcare expenditure.

    New opportunities lie in:

    • Develop AI-driven analytics for real-time arrhythmia detection.
    • Expand telehealth solutions for remote patient monitoring.
    • Invest in wearable devices with enhanced data integration capabilities.

    By 2035, the market is expected to achieve substantial growth, reflecting advancements in technology and increased demand.

    Market Segmentation

    Key Players

    • Spacelabs Healthcare (US)
    • GE Healthcare (US)
    • Biotronik (Germany)
    • Alive Cor Inc. (US)
    • Nihon Kohden Corporation (Japan)
    • Medtronic plc (Ireland)
    • Applied Cardiac Systems Inc. (US)
    • Fukuda Denshi Co. Ltd (Japan)
    • BioTelemetry Inc. (US)
    • Abbott Laboratories (US)

    Arrhythmia Monitoring Devices Market Industry Developments

    • Q2 2024: Medtronic receives FDA approval for LINQ II™ insertable cardiac monitor for pediatric patients Medtronic announced FDA approval for its LINQ II™ insertable cardiac monitor to be used in pediatric patients, expanding its arrhythmia monitoring device portfolio for younger populations.
    • Q2 2024: Abbott launches new Jot Dx™ insertable cardiac monitor in the U.S. Abbott introduced the Jot Dx™ insertable cardiac monitor in the United States, designed to provide advanced arrhythmia detection and remote monitoring capabilities for clinicians and patients.
    • Q3 2024: Boston Scientific announces acquisition of Preventice Solutions Boston Scientific completed the acquisition of Preventice Solutions, a company specializing in remote cardiac monitoring and wearable arrhythmia detection devices, strengthening its position in the arrhythmia monitoring sector.
    • Q3 2024: iRhythm Technologies appoints new CEO Quentin Blackford iRhythm Technologies, a leader in ambulatory cardiac monitoring, announced the appointment of Quentin Blackford as Chief Executive Officer to drive growth and innovation in arrhythmia monitoring solutions.
    • Q4 2024: Philips launches next-generation wearable ECG patch for arrhythmia detection Philips unveiled a new wearable ECG patch designed for continuous arrhythmia monitoring, offering improved comfort and data accuracy for patients in ambulatory settings.
    • Q4 2024: Biotronik receives CE Mark for BioMonitor IV implantable cardiac monitor Biotronik announced it has received CE Mark approval for its BioMonitor IV implantable cardiac monitor, enabling expanded use of the device for arrhythmia detection in Europe.
    • Q1 2025: Hill-Rom Holdings opens new cardiac monitoring device manufacturing facility in Texas Hill-Rom Holdings inaugurated a new manufacturing facility in Texas dedicated to the production of advanced cardiac arrhythmia monitoring devices, aiming to meet rising demand in North America.
    • Q1 2025: Vivaquant raises $25M Series B to expand arrhythmia monitoring device development Vivaquant secured $25 million in Series B funding to accelerate the development and commercialization of its next-generation arrhythmia monitoring devices.
    • Q2 2025: GE Healthcare partners with Mindray Medical to co-develop AI-powered arrhythmia monitoring solutions GE Healthcare and Mindray Medical announced a strategic partnership to jointly develop artificial intelligence-powered arrhythmia monitoring devices for global markets.
    • Q2 2025: iRhythm Technologies completes $100M public offering to fund arrhythmia monitoring device R&D iRhythm Technologies completed a $100 million public offering, with proceeds earmarked for research and development of new ambulatory arrhythmia monitoring devices.
    • Q3 2025: Boston Scientific receives FDA clearance for LUX-Dx™ insertable cardiac monitor Boston Scientific announced FDA clearance for its LUX-Dx™ insertable cardiac monitor, expanding its portfolio of devices for long-term arrhythmia detection.
    • Q3 2025: Abbott partners with Schiller AG to distribute arrhythmia monitoring devices in Asia-Pacific Abbott entered into a distribution partnership with Schiller AG to expand the reach of its arrhythmia monitoring devices across the Asia-Pacific region.

    Report Scope

    Report Attribute/Metric Details
      Market Size 2032   USD 8.20 Billion
      CAGR   9.32% (2024-2032)
      Base Year   2023
      Forecast Period   2024-2032
      Historical Data   2020
      Forecast Units   Value (USD Billion)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Device Type, Application, End User, Region
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Abbott Laboratories (US), BioTelemetry Inc. (US), Fukuda Denshi Co. Ltd (Japan), Applied Cardiac Systems Inc. (US), Medtronic plc (Ireland), Nihon Kohden Corporation (Japan), Alive Cor Inc. (US), Biotronik (Germany), GE Healthcare (US), Spacelabs Healthcare (US)
      Key Market Opportunities   Growing Incidence of CVDs to Offer Market Expansion Opportunities
      Key Market Drivers   Innovation in Product to Grow the Adoption of Device among Professionals

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What would be the worth of the arrhythmia monitoring devices market by 2032?

    The arrhythmia monitoring devices market would be worth USD 8.20 Billion by 2032.

    At what speed the arrhythmia monitoring devices market would grow during the forecast period of 2024-2032?

    The arrhythmia monitoring devices market is showing signs of 9.32% CAGR during the forecast period of 2024-2032.

    What could prevent the arrhythmia monitoring devices market from having a normal growth?

    The arrhythmia monitoring devices market growth can be deterred by the high cost of the remote monitoring system and notable product recalls.

    Which end user segment would influence the arrhythmia monitoring devices market the most?

    The hospitals & clinics segment would dominate the arrhythmia monitoring devices market.

    Which regional arrhythmia monitoring devices market would dominate the global market?

    The Americas have the chance to rule the arrhythmia monitoring devices market.

    Arrhythmia Monitoring Devices Market Research Report - Forecast till 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials